Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01712555 · ClinicalTrials.gov registry record · NA
Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets
A NA study of Orbital Atrophy, sponsored by Fox, Donald Munro, M.D., P.C..
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01712555 is a NA study of Orbital Atrophy that has completed, run by Fox, Donald Munro, M.D., P.C.. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01712555, a NA study of Orbital Atrophy, has completed, sponsored by Fox, Donald Munro, M.D., P.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various gels (Restylane, Radiesse) are temporary had have their own disadvantages. This study seeks to demonstrate an improvement in the retention of injected autologous fat by mixing in autologous PRP (platelet rich plasma).
Conditions Studied
Interventions
- PROCEDURE autologous fat grafting with PRP to anophthalmic orbits
Study Locations (1)
New York
- New York Eye and Ear Infirmary - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-12 |
| Est. Completion | 2017-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01712555
The ClinicalTrials.gov registry entry for NCT01712555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox, Donald Munro, M.D., P.C., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Orbital Atrophy appearing as the primary indexed condition, and to 1 intervention - of which autologous fat grafting with PRP to anophthalmic orbits is the first listed.
NCT01712555 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01712555 about?
NCT01712555 is a clinical study titled "Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets". After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various ge...
What is the current status of trial NCT01712555?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-12. Estimated completion is 2017-12-15.
What conditions does trial NCT01712555 study?
This clinical trial studies the following conditions: Orbital Atrophy.
What interventions are being tested in trial NCT01712555?
The interventions under investigation include: autologous fat grafting with PRP to anophthalmic orbits (PROCEDURE).
Who is sponsoring clinical trial NCT01712555?
This trial is sponsored by Fox, Donald Munro, M.D., P.C., which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01712555 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.